EcoDrugPlus

Toll Like Receptor 8

Ensembl ID : ENSAOCG00000017425
Gene Symbol: TLR8
4 Cross references
185 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSAOCG00000005540
Gene Symbol: TAAR1
2 Cross references
384 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSAOCG00000004182
Gene Symbol: TAAR1
3 Cross references
432 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSAOCG00000005522
Gene Symbol: TAAR1
1 Cross references
432 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSAOCG00000004175
Gene Symbol: TAAR1
1 Cross references
432 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSAOCG00000005558
Gene Symbol: TAAR1
3 Cross references
384 Possible Orthologues:

Transcription Factor P65-Like

Ensembl ID : ENSAOCG00000022580
Gene Symbol: LOC111582710
3 Cross references
201 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily A Member 1

Ensembl ID : ENSAOCG00000003095
Gene Symbol: TRPA1
3 Cross references
201 Possible Orthologues:

Transmembrane O-Methyltransferase Homolog

Ensembl ID : ENSAOCG00000009005
Gene Symbol: LOC111578177
2 Cross references
176 Possible Orthologues:

Transthyretin-Like

Ensembl ID : ENSAOCG00000024507
Gene Symbol: LOC111569632
3 Cross references
180 Possible Orthologues:

Trifunctional Purine Biosynthetic Protein Adenosine-3-Like

Ensembl ID : ENSAOCG00000016683
Gene Symbol: LOC111587996
2 Cross references
212 Possible Orthologues:

Tryptophan Hydroxylase 1

Ensembl ID : ENSAOCG00000017657
Gene Symbol: TPH1
3 Cross references
202 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).